Markets:

Overview

News

Currencies

International

Treasuries

Lexicon Pharmaceuticals, Inc. - Common Stock (NQ:LXRX)

1.410 -0.010 (-0.70%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lexicon Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

81 Biggest Movers From Yesterday ↗

November 05, 2021

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) jumped 79.8...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 04, 2021

Gainers Evaxion Biotech (NASDAQ:EVAX) shares increased by 244.61% to $22.4 during Thursday's pre-market session. The company's market cap stands at $430.0 million...

Via Benzinga

Recap: Lexicon Pharmaceuticals Q3 Earnings ↗

November 03, 2021

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 06, 2021

Gainers Voyager Therapeutics (NASDAQ:VYGR) shares increased by 46.15% to $3.61 during Wednesday's pre-market session. The company's market cap stands at $136.9...

Via Benzinga

Why Cramer Likes Bank of America, Ethereum And More ↗

October 06, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Bank of America Corp (NYSE: BAC). He met the CFO over the weekend and Cramer thinks it's a...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 30, 2021

Gainers Valneva (NASDAQ:VALN) stock rose 17.45% to $45.22 during Monday's pre-market session. The market value of their outstanding shares is at $2.2 billion....

Via Benzinga

60 Biggest Movers From Friday ↗

August 30, 2021

Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share. Navios Maritime Acquisition...

Via Benzinga

Lexicon Touts Analyses From Two Phase 3 Trials Of Its Heart Failure Drug ↗

August 23, 2021

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) has presented additional analyses from SOLOIST and SCORED Phase 3 trials evaluating heart failure candidate...

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

August 16, 2021

Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs ↗

July 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Lexicon Pharmaceuticals: Q2 Earnings Insights ↗

July 30, 2021

Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were up 80.00% over the past year...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 16, 2021

Gainers Moderna (NASDAQ:MRNA) stock increased by 7.67% to $279.6 during Friday's pre-market session. The company's market cap stands at $112.2 billion. Eton...

Via Benzinga

55 Biggest Movers From Friday ↗

June 28, 2021

Gainers IKONICS Corporation (NASDAQ: IKNX) shares surged 64.3% to close at $18.56 on Friday after the company reported a merger deal with TeraWulf. Alpha Teknova, Inc. (NASDAQ:...

Via Benzinga

Earnings Scheduled For July 30, 2021 ↗

July 30, 2021

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its second quarter. • Embraer (NYSE:ERJ) is...

Via Benzinga

Recap: Lexicon Pharmaceuticals Q1 Earnings ↗

May 06, 2021

Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 76.19% over the...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Lexicon Pharmaceuticals, Inc. - Common Stock (NQ:LXRX)

All News about Lexicon Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today